Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
about
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDThe importance of relative standards in ADHD diagnoses: evidence based on exact birth datesUsing Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in YouthsA review of the economic burden of ADHDAssociation between variation in neuropsychological development and trajectory of ADHD severity in early childhood.Childhood lead poisoning: conservative estimates of the social and economic benefits of lead hazard controlUpdate on optimal use of lisdexamfetamine in the treatment of ADHD.[Calculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Comparison of methods].Children diagnosed with attention deficit disorder and their hospitalisations: population data linkage study.Mediating Effect of Depressive Symptoms on the Relationship between Adult Attention Deficit Hyperactivity Disorder and Quality of Life.Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder.Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case.The Estimated Annual Cost of ADHD to the U.S. Education System.Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD.A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults.The role of neuropsychological assessment in the functional outcomes of children with ADHD.ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity DisorderMoment-to-moment dynamics of ADHD behaviour in South African children.Cost-of-illness studies: concepts, scopes, and methodsWhite matter microstructure and the variable adult outcome of childhood attention deficit hyperactivity disorder.Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skillsA cross-sectional analysis of video games and attention deficit hyperactivity disorder symptoms in adolescents.Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysisCaregiver Preferences Regarding Personal Health Records in the Management of ADHD.Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands.Service use patterns for adolescents with ADHD and comorbid conduct disorderCost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescentsAlpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.Mind how you cross the gap! Outcomes for young people who failed to make the transition from child to adult services: the TRACK study.ADHD from a socio-economic perspective.Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study.Origins of altered reinforcement effects in ADHD.Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years.Language ability predicts the development of behavior problems in childrenNeuropsychological functioning and severity of ADHD in early childhood: a four-year cross-lagged studyProfiles of service utilization and the resultant economic impact in preschoolers with attention deficit/hyperactivity disorder.Cognitive and behavioral indicators of ADHD symptoms prior to school ageCommentary: why diagnose and treat ADHD in adults?Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood.
P2860
Q21260332-3F5C0A06-B8E2-46EA-A7D8-E643EC79AAF2Q22252388-11E5447A-9865-4A16-BD8A-3C6C818D7BAEQ24642024-B38D6146-125B-4AA0-AF1A-3E954DA096E8Q24815063-7340ED7C-0B08-4B65-9200-92227A1EF5A2Q27329573-621AC3E2-CD15-4914-9743-7435B0E76E2FQ28389942-42202E1C-4DB8-426C-BFA6-B0C312177A81Q30418053-4D5DA73E-9CB8-4D40-AA3E-85AA9CA7E9DDQ30596477-DD6DC13F-7925-451F-95D9-D02E080E76E9Q30809991-979A6745-B502-42DB-9916-E35B4265DC2AQ33620345-8F2FA9EA-6351-49CA-B6E6-5DF4785A1FEEQ33800284-28BFC600-D74F-42FF-B751-893A6619A89AQ33829034-11FC7AB0-F6F1-4544-9662-73246C6AE686Q34010371-0D1941EE-9332-4B69-AD6A-90658364C6BEQ34041439-6E582741-9B83-4CF5-8223-C0598C0801DAQ34066407-F975E91B-CF01-422A-B5E7-AF171C8161F9Q34162864-9D7868EA-8720-4811-8B1E-2F93D6DDD7F0Q34232359-0F0F067F-B07D-4F3E-8EF4-44A940CDFF45Q34493964-3C5B3CE0-1B9F-47BF-8348-CB636C704C7AQ34722355-5C4F9A0F-54B8-403E-8DC9-1C8F8186022AQ34779725-C498597C-8E46-4140-BEB5-EC931E2824DEQ34907007-0F08D734-1824-4A80-8517-70A6AE1AD6DAQ35065125-ADD14B6D-0D4D-4717-A85B-F61712E2C809Q35129054-BDE6468B-81F8-40BF-BEC1-13774A2CBB0CQ35252145-C8487367-9F5D-41FC-950E-93B464E1E30CQ35761491-5B2D6C63-26F8-4237-B7B9-D7328CAAB9D9Q35807563-6526BBEB-E495-466A-B192-2EEA9D5775AAQ36500967-19F91E56-8B9B-4F3A-A3C8-83634EF5BFB4Q36623089-7F9632D4-7430-42B6-9D75-6E2C358E9DCEQ36914029-68B5E8D0-1185-4F13-AFC6-BFFDADB925E0Q36953227-4A7CB713-5F12-4E2B-9A6B-AE1EBD87275CQ37078464-97DF1484-E960-4B63-8BAA-DC443E5E597DQ37087432-578A4B85-0C57-4D81-A142-5E9FE0D60FBDQ37114200-D94F85F4-56B2-4C53-98DD-0DF77FD1FE57Q37126206-CF98BF67-F16D-4C71-9830-8B3205546C57Q37139825-92DC5986-B497-44E6-AA3A-DCB50FDEE9CCQ37166686-C497379B-6F14-4946-945C-31E8852A2593Q37234663-730E4EA8-10AF-48AE-B33D-1772B2792DDEQ37275118-3B514F68-28CD-4E1F-924B-ACC68511C559Q37282154-10DF2312-882B-4DF0-9785-D5886DDDAF72Q37282163-9A0270C2-4602-4915-A90E-A445855524D7
P2860
Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Costs of attention deficit-hyp ...... their family members in 2000.
@en
type
label
Costs of attention deficit-hyp ...... their family members in 2000.
@en
prefLabel
Costs of attention deficit-hyp ...... their family members in 2000.
@en
P2093
P356
P1476
Costs of attention deficit-hyp ...... their family members in 2000.
@en
P2093
Andrine R Swensen
Howard G Birnbaum
Kristina Secnik
Paul E Greenberg
Sarah W Lowe
Stephanie A Leong
P304
P356
10.1185/030079904X20303
P407
P577
2005-02-01T00:00:00Z